Search: WFRF:(Bonanni Laura) >
Cerebrospinal fluid...
Cerebrospinal fluid Alzheimer's disease biomarkers across the spectrum of lewy body diseases : Results from a large multicenter cohort
-
- Van Steenoven, Inger (author)
- Amsterdam UMC - Vrije Universiteit Amsterdam
-
- Aarsland, Dag (author)
- Karolinska Institutet
-
- Weintraub, Daniel (author)
- University of Pennsylvania
-
show more...
-
- Londos, Elisabet (author)
- Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups
-
- Blanc, Frederic (author)
- University Hospital Of Strasbourg
-
- Van Der Flier, Wiesje M. (author)
- Amsterdam UMC - Vrije Universiteit Amsterdam
-
- Teunissen, Charlotte E. (author)
- Amsterdam UMC - Vrije Universiteit Amsterdam
-
- Mollenhauer, Brit (author)
- University of Göttingen
-
- Fladby, Tormod (author)
- Akershus University Hospital
-
- Kramberger, Milica G. (author)
- University Medical Centre Ljubljana
-
- Bonanni, Laura (author)
- University G.d'Annunzio of Chieti-Pescara
-
- Lemstra, Afina W. (author)
- Amsterdam UMC - Vrije Universiteit Amsterdam
-
Blanc, 'E (author)
-
show less...
-
(creator_code:org_t)
- 2016
- 2016
- English 9 s.
-
In: Journal of Alzheimer's Disease. - 1387-2877 .- 1875-8908. ; 54:1, s. 287-295
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://lup.lub.lu.s...
-
https://doi.org/10.3...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Background: Concomitant Alzheimer's disease (AD) pathology is observed in Lewy body diseases (LBD), but the clinical impact is unknown. Only a few biomarker studies in LBD exist and have included small cohorts from single centers. Objective: We aimed to evaluate the prevalence of abnormal cerebrospinal fluid (CSF) AD biomarkers across the spectrum of LBD in a large multicenter cohort and to assess whether an AD biomarker profile was associated with demographic and clinical differences in dementia with Lewy bodies (DLB). Methods:We included 375 DLB patients, 164 Parkinson's disease (PD) patients without dementia, and 55 PD patients with dementia (PDD) from 10 centers. CSF amyloid-beta42 (Aβ42), total tau (t-tau), and phosphorylated tau (p-tau) values were dichotomized as abnormal or normal according to locally available cut-off values. A CSF AD profile was defined as abnormal Aβ42 combined with abnormal t-tau and/or p-tau. Results: A substantial proportion of DLB patients had abnormal values for CSF Aβ42, t-tau, and p-tau, while abnormal values were uncommon in PD without dementia. Patients with PDD had values in between. A CSF AD profile was observed in 25% of DLB patients, compared with only 9% of PDD and 3% of PD without dementia.Within DLB, patients with a CSF AD profile were older, more often female, performed worse on the Mini-Mental State Examination, and had shorter disease duration compared with patients with normal CSF. Conclusion: A CSF AD profile is more common in DLB compared with PDD and PD, and is associated with more severe cognitive impairment in DLB.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Keyword
- Amyloid beta-protein (1-42)
- Biomarkers
- Cerebrospinal fluid
- Dementia with Lewy bodies
- Lewy body disease
- Tau protein
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database
- By the author/editor
-
Van Steenoven, I ...
-
Aarsland, Dag
-
Weintraub, Danie ...
-
Londos, Elisabet
-
Blanc, Frederic
-
Van Der Flier, W ...
-
show more...
-
Teunissen, Charl ...
-
Mollenhauer, Bri ...
-
Fladby, Tormod
-
Kramberger, Mili ...
-
Bonanni, Laura
-
Lemstra, Afina W ...
-
Blanc, 'E
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Neurology
- Articles in the publication
-
Journal of Alzhe ...
- By the university
-
Lund University
-
Karolinska Institutet